Experts call for accelerated development of function-promoting therapies for older adults

FHS
June 28, 2023
5:51 pm

Experts have identified a public health need as well as strategic opportunities for the accelerated development of function-promoting therapies for older adults -; and present new research on this topic in a supplemental issue of The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences inspired by a March 2022 workshop convened by the National Institute on Aging (NIA), part of the National Institutes of Health.

Breast cancer survivors at higher risk of developing second cancers

Survivors of breast cancer are at significantly higher risk of developing second cancers, including endometrial and ovarian cancer for women and prostate cancer for men,

April 25, 2024

Research highlights need for clear guidelines on healthy hydration

Adequate water intake is essential for human health and well-being. But around the world, the consumption of sugary beverages has risen and accelerated health challenges

August 31, 2024

Sanofi and Regeneron’s Dupixent scores second win in Phase III COPD trial

Share this article Dupixent is an interleukin-4 receptor alpha antagonist monoclonal antibody. Image Credit: Net Vector / Shutterstock. Sanofi and Regeneron have reported positive interim

November 27, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.